Expression of secretory group IIA phospholipase A2 in relation to the presence of microbial agents, macrophage infiltrates, and transcripts of proinflammatory cytokines in human aortic tissues

被引:30
作者
Menschikowski, M
Rosner-Schiering, A
Eckey, R
Mueller, E
Koch, R
Jaross, W
机构
[1] Tech Univ Dresden, Inst Klin Chem & Lab Med, Med Fak Carl Gustav Carus, D-01307 Dresden, Germany
[2] Tech Univ Dresden, Inst Informat & Biometrie, Med Fak Carl Gustav Carus, D-01307 Dresden, Germany
[3] Tech Univ Dresden, Inst Rechtsmed, Med Fak Carl Gustav Carus, D-01307 Dresden, Germany
关键词
infections; secretory phospholipase A(2); inflammation; atherosclerosis;
D O I
10.1161/01.ATV.20.3.751
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent seroepidemiological and immunohistochemical studies have demonstrated an association between microbial infections and atherosclerosis. However, the mechanisms underlying this association are widely unknown. In the present study, arterial specimens obtained at autopsy after sudden death were analyzed concerning (1) the presence of Chlamydia pneumoniae, cytomegalovirus, herpes simplex virus, and Helicobacter pylori; (2) the expression of secretory group IIA phospholipase A(2) (sPLA(2)-IIA) and of proinflammatory cytokines; and (3) the stage of atherosclerosis. Genomic DNA of microbial pathogens was determined by the polymerase chain reaction technique. The expression of sPLA(2)-IIA was studied immunohistochemically by using monoclonal antibodies against human sPLA(2)-IIA. Transcripts specific for sPLA(2)-IIA, interleukin-1 beta, tumor necrosis factor-alpha, and interferon-gamma were identified by reverse transcription-polymerase chain reaction. In 18 of 102 analyzed specimens, DNA of microbial pathogens was found. Thirteen sections were positive for C pneumoniae, whereas 2 specimens were positive either for cytomegalovirus or for herpes simplex virus. One section contained genomic DNA of all 3 pathogens simultaneously. None of the analyzed tissues exhibited nucleic acids specific for H pylori. In addition to macrophage infiltrates, the presence of microbial DNA was closely associated with the occurrence of transcripts specific for proinflammatory cytokines and sPLA(2)-IIA. Pathogens as well as sPLA(2)-IIA and cytokines were found to be present not only in advanced but also in early stages of atherosclerosis. In tissues negative for sPLA(2)-IIA and cytokine expression, none of the pathogens could be identified. Because macrophages exposed to phospholipase A(2)-treated lipoproteins are transformed into foam cells in vitro, the results of this study suggest an alternative mechanism by which microbial infections may act in a proatherogenic fashion in vessel walls.
引用
收藏
页码:751 / 762
页数:12
相关论文
共 56 条
[41]  
OSLER W, 1908, MODERN MED ITS THEOR, P426
[42]  
POOLE A, 1979, NATURE, V227, P810
[43]   Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears [J].
Qu, XD ;
Lehrer, RI .
INFECTION AND IMMUNITY, 1998, 66 (06) :2791-2797
[44]   LYSOPHOSPHATIDYLCHOLINE - A CHEMOTACTIC FACTOR FOR HUMAN-MONOCYTES AND ITS POTENTIAL ROLE IN ATHEROGENESIS [J].
QUINN, MT ;
PARTHASARATHY, S ;
STEINBERG, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2805-2809
[45]   Interaction of Chlamydia pneumoniae and human alveolar macrophages:: Infection and inflammatory response [J].
Redecke, V ;
Dalhoff, K ;
Bohnet, S ;
Braun, J ;
Maass, M .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 19 (05) :721-727
[46]   Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries [J].
Romano, M ;
Romano, E ;
Björkerud, S ;
Hurt-Camejo, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (04) :519-525
[47]   THE PATHOGENESIS OF ATHEROSCLEROSIS - AN UPDATE [J].
ROSS, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (08) :488-500
[48]  
ROSS R, 1993, AM J PATHOL, V143, P987
[49]   Phospholipase A2 type-II binds to extracellular matrix biglycan -: Modulation of its activity on LDL by colocalization in glycosaminoglycan matrixes [J].
Sartipy, P ;
Bondjers, G ;
Hurt-Camejo, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (12) :1934-1941
[50]  
SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335